ABC Money
Home

N.J. stem cell center advances


Published :
Tue, 12 Jun 2007 22:05
By : Agencies
Print this Story


AddThis Social Bookmark Button

TRENTON, N.J. (AP) - New Jersey has approved the first funding to build a state stem cell research facility touted by Gov. Jon S. Corzine as key to combating federal restrictions on embryonic stem cell work.

The New Jersey Economic Development Authority on Tuesday approved $9.2 million in preconstruction costs for the Stem Cell Institute of New Jersey in New Brunswick, which the governor said would attract the world's best researchers and boost the state's economy.

Corzine, a Democrat, deemed the funding 'an important first step in our growing partnership with private industry to fund this promising and potentially life saving science.'

'At a time when the Bush administration is pursuing a misguided policy on stem cells, I am proud that New Jersey is leading the way in promoting this lifesaving research,' the governor said.

Embryonic stem cells are created in the first days after conception and give rise to all the organs and tissues in the human body.

But while scientists hope they can someday use embryonic stem cells to replace diseased tissue, many social conservatives, including President Bush, oppose such work because embryos are destroyed during research.

In 2001, Bush imposed strict guidelines on embryonic stem cell work that scientists contend hinders research. In response, several states, including New Jersey, are paying for it themselves to skirt the federal restrictions.

California voters have approved spending $3 billion on stem cell research in the next 10 years; Connecticut has a $100 million stem cell research program; Illinois spent $10 million last year; and Maryland recently awarded $15 million in grants.

Massachusetts Gov. Deval Patrick has proposed spending $1 billion in the biotechnology industry, including stem-cell research.

The Stem Cell Institute of New Jersey will be built in downtown New Brunswick, adjacent to Robert Wood Johnson University Hospital and across the street from the Cancer Institute of New Jersey. It will feature facilities for research and outpatient treatment, and be a collaborative effort between The University of Medicine and Dentistry of New Jersey and Rutgers University.

Marie Tasy, executive director of New Jersey Right to Life, which opposes embryonic stem cell research, expressed dismay at the plans.

'The taxpayers should be outraged,' Tasy said.

The state is currently looking for a director to run the $150 million institute, which will be paid for with bonds issued by the Economic Development Authority.

The money will pay for design, engineering and other preconstruction requirements, though it was unclear Tuesday when construction would begin and be completed.

'We can create the climate to facilitate this important research, while at the same time growing our economy with well paying jobs,' Corzine said.

The state also plans to spend $50 million to build stem cell research facilities at the New Jersey Institute of Technology in Newark; $50 million on a biomedical research center in Camden; $10 million to support research at the Garden State Cancer Center and $10 million to do the same at the Eli Katz Umbilical Cord Blood Program in Allendale.

Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.




Share on


 You Might Like
Mass. governor pushes biotech investment
Wis. gives stem cell company $1M
+
Stem cell debate rekindles in Michigan
Cleveland BioLabs cites Protectan study

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
10340.69
-107.24 ( -1.03 %)
NASDAQ
2792.28
22.57 ( 0.81 %)
FTSE 100
5741.15
38.78 ( 0.68 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
STANDARD CHARTERED ( 11:35am )
1559.00
70.00 ( 4.76 %)
WOLSELEY PLC ( 11:35am )
2250.00
70.00 ( 3.20 %)
CARNIVAL ( 11:35am )
2017.00
46.00 ( 2.42 %)
LAND SECURITIES GROUP ( 11:35am )
679.50
36.50 ( 5.63 %)
WHITBREAD ( 11:35am )
1662.99
33.99 ( 2.09 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
3M COMPANY ( 12:34pm )
85.78
0.71 ( 0.83 %)
BOEING CO ( 12:34pm )
75.70
0.64 ( 0.85 %)
JP MORGAN CHASE CO ( 12:34pm )
37.03
0.49 ( 1.33 %)
WAL MART STORES ( 12:34pm )
60.44
0.43 ( 0.72 %)
IBM ( 12:34pm )
181.50
0.43 ( 0.24 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
F5 NETWORKS INC ( 12:11pm )
122.38
13.92 ( 11.80 %)
ICO GLOBAL COMM CL A ( 8:01pm )
99999999.99
9.37 ( 366.02 %)
PRICELINECOM INC ( 12:23pm )
525.40
6.57 ( 1.26 %)
AMAZONCOM INC ( 12:04pm )
195.65
6.21 ( 3.25 %)
MILLICOM INTERNATIONAL CELLULAR SA ( 4:00pm )
110.18
4.82 ( 4.43 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!


 Finance Explained

Money making ideas

Save money

Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.